Cryoport Announces Multi-Year Agreement with Inception Fertility

Cryoport to Support The Prelude Network® and MyEggBank®’s Reproductive Material Shipments with its end-to-end supply chain solutions

Cryoport, Inc. a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences industry and a leader in supply chain solutions for the reproductive medicine markets, today announced a multi-year agreement with Inception Fertility™ (Inception), North America’s largest provider of comprehensive fertility services. Inception Fertility operates The Prelude Network® (Prelude), the largest and fastest-growing technology-led network of fertility centers in North America, and MyEggBank®, one of the largest and most diverse networks of donor egg banks and practices in North America.

Through this three-year partnership, Prelude and MyEggBank will continue to utilize Cryoport’s end-to-end supply chain solutions for egg and embryo shipments across their clinical networks to ensure significant risk mitigation for families using these services. Additionally, Prelude’s patient medical record system will be integrated with Cryoport’s Cryoportal® 2.0, which will merge each shipment’s tracking, condition monitoring and equipment qualification data into a single data stream, providing better service to Inception and Prelude’s patients.

“Our team is steadfast in its mission to utilize the most advanced, scientifically enhanced technology and nonstop monitoring to provide our partners — and the families behind these shipments — with peace of mind throughout the fertility journey,” said Jerrell Shelton, CEO of Cryoport. “In 2022, we had a 99% success rate in global reproductive medicine shipments, and we look forward to deepening our partnership with Inception Fertility for many years to come to create a superior patient experience as Inception’s network capabilities continue to grow and expand.”

“Making certain that patients’ reproductive materials are safe at every touchpoint during the fertility transport journey is of the utmost importance as we serve a growing number of clients across the globe who trust us to handle these materials with care,” added T.J. Farnsworth, CEO of Inception Fertility. “Over the past three years, Cryoport has become an essential partner to the Inception team. The data that we obtain through working with Cryoport gives us invaluable insights into the entire supply chain process, ensuring that we’re continuing to work efficiently to meet the unique needs of each aspiring parent.”

Company: CryoPort Inc

Cryoport is a trusted global provider of solutions for maintaining temperature-sensitive life sciences commodities during distribution, serving the biopharmaceutical market with leading-edge logistics solutions for biologic materials, such as regenerative medicine, including immunotherapies, stem cells and CAR-T cells. Cryoport’s solutions are used by points-of-care, CRO’s, central laboratories, pharmaceutical companies, manufacturers, university researchers et al; as well as the reproductive medicine market, primarily in IVF and surrogacy; and the animal health market, primarily in the areas of vaccines and reproduction. Cryoport’s proprietary Cryoport Express® Shippers, Cryoportal® Logistics Management Platform, leading-edge SmartPak II™ Condition Monitoring System and geo-sensing technology, paired with unparalleled cold chain logistics expertise and 24/7 client support, make Cryoport the end-to-end cold chain logistics partner that the industry trusts.

Send Enquiry for this story

By submitting this form you are giving a consent to to store your submitted information.
See our Privacy Policy to learn more about how we use data.